Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The website has been updated from version v2.10.2 to v2.10.3.
    Difference
    0.3%
    Check dated 2024-09-04T01:57:31.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A new addition was made on August 22, 2024, while a previous entry was deleted on May 23, 2024.
    Difference
    0.7%
    Check dated 2024-08-28T01:37:24.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-13T20:56:12.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The website has added new functionality for viewing and comparing study record versions in the latest update (v2.10.0), replacing the previous version (v2.9.7).
    Difference
    6%
    Check dated 2024-07-23T13:39:15.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.3%
    Check dated 2024-07-16T06:34:43.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.3%
    Check dated 2024-07-02T14:01:44.000Z thumbnail image

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.